Found 8 matching trials
Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.
EARLY_PHASE1Gliomas are a heterogeneous group of tumors arising from glial cells in the...
Location
Biogenea Pharmaceuticals Ltd
Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma
PHASE1The purpose of this research study is to see if the combination of HSPPC-96...
Location
UTHealth Memorial Hermann Cancer Center
Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma
PHASE3The primary goal of this study is to determine if people with metastatic me...
Location
Multiple Locations
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
PHASE2Background:
Glioblastoma (GBM) refers to a specific kind of brain cancer c...
Location
National Institutes of Health Clinical Center
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
PHASE1Vaccines made from a person's tumor cells, such as gp96 heat shock protein-...
Location
University of California, San Francisco
Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer
PHASE1RATIONALE: Vaccines made from a person's cancer cells may make the body bui...
Location
Memorial Sloan-Kettering Cancer Center
Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
PHASE1The purpose of this study is to determine whether Heat Shock Protein Peptid...
Location
Ann & Robert H. Lurie Children's Hospital of Chicago
HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM
PHASE2This phase II trial studies the side effects and how well HSPPC-96 (vitespe...
Location
University of California, San Francisco